WA-VIRTUOZZO
15.3.2022 12:02:04 CET | Business Wire | Press release
Virtuozzo , the alternative cloud platform leader, announced today that it will preview at CloudFest 2022 two never-before-seen solutions designed to help service providers bring to market modern cloud-based solutions that answer long-ignored market needs. The products are the PaaS-focused Virtuozzo Application Platform for WordPress and Virtuozzo Hybrid Server Lite. Framing their value proposition, Virtuozzo executives will deliver two keynote presentations outlining the current industry trends and landscape shaping the need for those services. The sessions will also introduce practical strategies for service providers to integrate and deploy the new solutions in ways that help them increase competitive positioning while growing their business.
Attendees can visit Virtuozzo, a platinum event sponsor, at Stand C01 throughout the show (March 22 – 24) in Europa-Park, Germany. Additionally, a special on-site promotion will give service providers six months free licensing for key solutions showcased during the conference.
Virtuozzo: Bringing Cloud to All
As a company, Virtuozzo has strategically evolved over the last several years to fill a polarizing void in the cloud enablement market. The most common paths to the cloud leverage hyperscaler or enterprise-centric platforms that are generally inflexible, cost-prohibitive, and too complex for non-specialized end users to manage. This puts many businesses, particularly small- to medium-sized ones, at a disadvantage. Which is where Virtuozzo comes in.
“There was an inherent promise in the beginning that cloud would be easy. Accessible to all. In reality, that is not how things panned out,” said Alex Fine, CEO, Virtuozzo. “Virtuozzo is solving that problem through collaborative partnerships with service providers that empower them to become full-service, alternative cloud providers.”
Virtuozzo develops and delivers the most comprehensive cloud platform stack purpose built for service providers. That infrastructure allows services providers to quickly carve out a wide portfolio of cloud services that are easy to use, easy to manage, and easy to scale. This frees them to then focus on areas where they can strongly differentiate, from the delivery of unique products and skills to high-touch customer support.
Virtuozzo Keynote Presentations
The Service Provider Landscape in 2022: Where is the Low-Hanging Fruit?
March 22 at 3:45 PM CET
Carlos Rego, Virtuozzo’s VP of Strategic Development, addresses the roller coaster ride that has been the experience of hosters, MSPs and cloud providers over the past decade. He provides expert perspective on the complex landscape they currently operate in, how the industry is evolving, and how these service providers can strategically grow their businesses without overly taxing their operations.
WordPress Hosting? It’s Time to Grow Up.
March 23 at 4:40 PM CET
In his second presentation, Carlos Rego will introduce viable revenue-generating opportunities surrounding the booming $500B+ WordPress economy. With new PaaS capabilities via Virtuozzo Application Platform for WordPress targeting business-critical WordPress sites, service providers can strengthen their businesses while helping modernize an enormous ecosystem that can be argued is antiquated today.
Schedule a Meeting
To meet with a Virtuozzo team member on site, contact info@Virtuozzo.com .
About Virtuozzo
Virtuozzo (www.virtuozzo.com ) provides the leading alternative cloud platform for service providers, enabling them to sell cloud services that are more accessible, more affordable and easier to use than hyperscaler solutions. The company’s legacy includes developing the first commercially available container technology and being a major contributor to numerous virtualization and open-source projects for more than 20 years. Today, Virtuozzo cloud solutions are used by more than 700 Cloud Service Providers, Managed Service Providers and Hosting Providers in 80 countries. Virtuozzo is based in Schaffhausen, Switzerland, and has more than 320 employees across the U.S., UK, Europe, and Asia-Pacific.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220315005472/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Secures €50M Financing to Accelerate Global Growth30.3.2026 08:00:00 CEST | Press release
€50 million financing package from funds and accounts managed by BlackRock will support IQM to scale operations, accelerate product development, and strengthen its market position. The facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing as IQM prepares for public listing. IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), today announced it has secured a €50 millionfinancing package from funds and accounts managed by BlackRock. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329996942/en/ IQM Radiance quantum computer is located in IQM's showroom in Espoo, Finland. This facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing. This
Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations30.3.2026 07:45:00 CEST | Press release
Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch Government Services Division, is pleased to announce a strategic agreement with Trade Technologies, the leading provider of trade finance automation, connectivity and transaction management services. This collaboration is a significant step toward reducing the complexities of international trade operations, particularly in regions where regulatory and inspection controls remain stringent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329411683/en/ Addressing Critical Trade Finance Challenges The agreement comes at a pivotal time for global trade. Letters of Credit (LCs) continue to serve as essential instruments in international commerce, particularly across the Middle East and Africa, where counterparty risk, foreign exchange controls, sanctions exposure, and regulatory oversight face ongoing challenges. In
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release
~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom